Chronobiological Therapy for Mood Disorders

Current Psychiatry Reports

Volumn 17, Issue 12, 2015, Pages

  Dallaspezia, Sara ^a   Suzuki, Masahiro ^b   Benedetti, Francesco ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bipolar disorder; Chronotherapeutics; Dark therapy; Depression; Light therapy; Mood disorder; Sleep deprivation; Sleep phase advance

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; PSYCHOTROPIC AGENT;

ANTERIOR CINGULATE; ANTIDEPRESSANT ACTIVITY; BRAIN REGION; CHRONOTHERAPY; CLINICAL EFFECTIVENESS; DARK THERAPY; DEPRESSION; HUMAN; LIGHT DARK CYCLE; MOOD DISORDER; PATIENT SAFETY; PHOTOTHERAPY; PREVALENCE; REVIEW; SEASONAL AFFECTIVE DISORDER; SLEEP DEPRIVATION; SLEEP THERAPY; SLEEP TIME; SLEEP WAKING CYCLE; STIMULUS RESPONSE; TREATMENT INDICATION; TREATMENT RESPONSE; CHRONOBIOLOGY; MOOD DISORDERS; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; SUICIDE;

CHRONOBIOLOGY PHENOMENA; CHRONOTHERAPY; HUMANS; MOOD DISORDERS; PSYCHOTROPIC DRUGS; SLEEP PHASE CHRONOTHERAPY; SUICIDE;

EID: 84945183541     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-015-0633-6     Document Type: Review

References (170)

1. Gao K, Kemp DE, Ganocy SJ, Muzina DJ, Xia G, Findling RL, et al. Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder. Bipolar Disord. 2008;10(8):907–15.
2. Nemeroff CB. Improving antidepressant adherence. J Clin Psychiatry. 2003;64 Suppl 18:25–30.
3. Akiskal HS, Benazzi F. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population? J Affect Disord. 2006;94(1–3):105–10.
4. Preskorn S, Werder S. Detrimental antidepressant drug-drug interactions: are they clinically relevant? Neuropsychopharmacology. 2006;31(8):1605–12. discussion 1613.
5. Pearlstein T. Perinatal depression: treatment options and dilemmas. J Psychiatry Neurosci. 2008;33(4):302–18.
6. Hanley GE, Brain U, Oberlander TF. Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behavior. Pediatr Res. 2015;78(2):174–80.
7. Holden C. Future brightening for depression treatments. Science. 2003;302(5646):810–3.
8. Wirz-Justice A, Benedetti F, Berger M, Lam RW, Martiny K, Terman M, et al. Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med. 2005;35(7):939–44.
9. Wirz-Justice A, Terman M, Oren DA, Goodwin FK, Kripke DF, Whybrow PC, et al. Brightening depression. Science. 2004;303(5657):467–9.
10. Benedetti F: Antidepressant chronotherapeutics for bipolar depression. Dialogues in Clinical Neuroscience. 2012; 14(4).
11. Steinberg H, Hegerl U. Johann Christian August Heinroth on sleep deprivation as a therapeutic option for depressive disorders. Sleep Med. 2014;15(9):1159–64.
12. Schulte W. Sequelae of sleep deprivation. Med Klin (Munich). 1959;54(20):969–73.
13. Pflug B, Tolle R. Therapy of endogenous depression using sleep deprivation. Practical and theoretical consequences. Nervenarzt. 1971;42(3):117–24.
14. Pflug B, Tolle R. Disturbance of the 24-hour rhythm in endogenous depression and the treatment of endogenous depression by sleep deprivation. Int Pharmacopsychiatry. 1971;6(3):187–96.
15. Vogel GW, Thurmond A, Gibbons P, Sloan K, Walker M. REM sleep reduction effects on depression syndromes. Arch Gen Psychiatry. 1975;32(6):765–77.
16. Barbini B, Colombo C, Benedetti F, Campori E, Bellodi L, Smeraldi E. The unipolar-bipolar dichotomy and the response to sleep deprivation. Psychiatry Res. 1998;79(1):43–50.
17. Kuhs H, Tolle R. Sleep deprivation therapy. Biol Psychiatry. 1991;29(11):1129–48.
18. Benedetti F, Riccaboni R, Locatelli C, Poletti S, Dallaspezia S, Colombo C. Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression. J Clin Psychiatry. 2014;75(2):133–40.
19. Nakken KO, Solaas MH, Kjeldsen MJ, Friis ML, Pellock JM, Corey LA. Which seizure-precipitating factors do patients with epilepsy most frequently report? Epilepsy Behav. 2005;6(1):85–9.
20. Fahndrich E. Effects of sleep deprivation on depressed patients of different nosological groups. Psychiatry Res. 1981;5(3):277–85.
21. Benedetti F, Zanardi R, Colombo C, Smeraldi E. Worsening of delusional depression after sleep deprivation: case reports. J Psychiatr Res. 1999;33(1):69–72.
22. Giedke H, Geilenkirchen R, Hauser M. The timing of partial sleep deprivation in depression. J Affect Disord. 1992;25(2):117–28.
23. Fahndrich E. sleep deprivation therapy of depressive syndromes in schizophrenic disorders (author’s transl). Nervenarzt. 1982;53(5):279–93.
24. Benedetti F, Smeraldi E. Neuroimaging and genetics of antidepressant response to sleep deprivation: implications for drug development. Curr Pharm Des. 2009;15(22):2637–49.
25. Benedetti F, Barbini B, Colombo C, Smeraldi E. Chronotherapeutics in a psychiatric ward. Sleep Med Rev. 2007;11(6):509–22.
26. Benedetti F, Barbini B, Fulgosi MC, Colombo C, Dallaspezia S, Pontiggia A, et al. Combined total sleep deprivation and light therapy in the treatment of drug-resistant bipolar depression: acute response and long-term remission rates. J Clin Psychiatry. 2005;66(12):1535–40.
27. Echizenya M, Suda H, Takeshima M, Inomata Y, Shimizu T: Total sleep deprivation followed by sleep phase advance and bright light therapy in drug-resistant mood disorders. J Affect Disord. 2012.
28. Colombo C, Benedetti F, Barbini B, Campori E, Smeraldi E. Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression. Psychiatry Res. 1999;86(3):267–70.
29. Frye MA, Helleman G, McElroy SL, Altshuler LL, Black DO, Keck Jr PE, et al. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry. 2009;166(2):164–72.
30. Schilgen B, Tolle R. Partial sleep deprivation as therapy for depression. Arch Gen Psychiatry. 1980;37(3):267–71.
31. Giedke H, Wormstall H, Haffner HT. Therapeutic sleep deprivation in depressives, restricted to the two nocturnal hours between 3:00 and 5:00. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14(1):37–47.
32. Benedetti F, Colombo C. Sleep deprivation in mood disorders. Neuropsychobiology. 2011;64(3):141–51.
33. Christodoulou GN, Malliaras DE, Lykouras EP, Papadimitriou GN, Stefanis CN. Possible prophylactic effect of sleep deprivation. Am J Psychiatry. 1978;135(3):375–6.
34. Papadimitriou GN, Christodoulou GN, Katsouyanni K, Stefanis CN. Therapy and prevention of affective illness by total sleep deprivation. J Affect Disord. 1993;27(2):107–16.
35. Riemann D, Wiegand M, Lauer CJ, Berger M. Naps after total sleep deprivation in depressed patients: are they depressiogenic? Psychiatry Res. 1993;49(2):109–20.
36. Hemmeter U, Bischof R, Hatzinger M, Seifritz E, Holsboer-Trachsler E. Microsleep during partial sleep deprivation in depression. Biol Psychiatry. 1998;43(11):829–39.
37. Gillin JC, Kripke DF, Janowsky DS, Risch SC. Effects of brief naps on mood and sleep in sleep-deprived depressed patients. Psychiatry Res. 1989;27(3):253–65.
38. Benedetti F, Fulgosi MC, Gavinelli C, Barbini B, Colombo C, Smeraldi E. Homeostatic and allostatic response to sleep deprivation in bipolar depression. Int J Psychiatry Clin Pract. 2007;11(4):316.
39. Benedetti F, Dallaspezia S, Fulgosi MC, Lorenzi C, Serretti A, Barbini B, et al. Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression. Am J Med Genet Part B-Neuropsychiatric Genet. 2007;144B(5):631–5.
40. Giedke H, Schwarzler F. Therapeutic use of sleep deprivation in depression. Sleep Med Rev. 2002;6(5):361–77.
41. Leibenluft E, Wehr TA. Is sleep deprivation useful in the treatment of depression? Am J Psychiatr. 1992;149(2):159–68.
42. Benedetti F, Colombo C. Sleep deprivation in mood disorders. Neuropsychobiology. 2011;64(3):141–51.
43. Benedetti F, Colombo C, Barbini B, Campori E, Smeraldi E. Ongoing lithium treatment prevents relapse after total sleep deprivation. J Clin Psychopharmacol. 1999;19(3):240–5.
44. Kvist J, Kirkegaard C. Effect of repeated sleep deprivation on clinical symptoms and the TRH test in endogenous depression. Acta Psychiatr Scand. 1980;62(5):494–502.
45. Roy-Byrne PP, Uhde TW. Post RM antidepressant effect of one night’s sleep deprivation: clinical and theoretical implications. In: Post RM, Ballenger JC, editors. Neurobiology of mood disorders. Baltimore: William & Wilkins; 1984. p. 817–35.
46. Neumeister A, Goessler R, Lucht M, Kapitany T, Bamas C, Kasper S. Bright light therapy stabilizes the antidepressant effect of partial sleep deprivation. Biol Psychiatry. 1996;39(1):16–21.
47. Colombo C, Lucca A, Benedetti F, Barbini B, Campori E, Smeraldi E. Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: replication of main effects and interaction. Psychiatry Res. 2000;95(1):43–53.
48. Albert R, Merz A, Schubert J, Ebert D. sleep deprivation and subsequent sleep phase advance stabilizes the positive effect of sleep deprivation in depressive episodes. Nervenarzt. 1998;69(1):66–9.
49. Berger M, Vollmann J, Hohagen F, Konig A, Lohner H, Voderholzer U, et al. Sleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: an open pilot trial in medicated and unmedicated patients. Am J Psychiatry. 1997;154(6):870–2.
50. Riemann D, Konig A, Hohagen F, Kiemen A, Voderholzer U, Backhaus J, et al. How to preserve the antidepressive effect of sleep deprivation: a comparison of sleep phase advance and sleep phase delay. Eur Arch Psychiatry Clin Neurosci. 1999;249(5):231–7.
51. Vollmann J, Berger M. Sleep deprivation with consecutive sleep-phase advance therapy in patients with major depression: a pilot study. Biol Psychiatry. 1993;33(1):54–7.
52. Benedetti F, Barbini B, Campori E, Fulgosi MC, Pontiggia A, Colombo C. Sleep phase advance and lithium to sustain the antidepressant effect of total sleep deprivation in bipolar depression: new findings supporting the internal coincidence model? J Psychiatr Res. 2001;35(6):323–9.
53. Voderholzer U, Valerius G, Schaerer L, Riemann D, Giedke H, Schwarzler F, et al. Is the antidepressive effect of sleep deprivation stabilized by a three day phase advance of the sleep period? A pilot study. Eur Arch Psychiatry Clin Neurosci. 2003;253(2):68–72.
54. Wu JC, Kelsoe JR, Schachat C, Bunney BG, DeModena A, Golshan S, et al. Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry. 2009;66(3):298–301.
55. Echizenya M, Suda H, Takeshima M, Inomata Y, Shimizu T. Total sleep deprivation followed by sleep phase advance and bright light therapy in drug-resistant mood disorders. J Affect Disord. 2013;144(1–2):28–33.
56. Benedetti F, Barbini B, Lucca A, Campori E, Colombo C, Smeraldi E. Sleep deprivation hastens the antidepressant action of fluoxetine. Eur Arch Psychiatry Clin Neurosci. 1997;247:100–3.
57. Bump GM, Reynolds 3rd CF, Smith G, Pollock BG, Dew MA, Mazumdar S, et al. Accelerating response in geriatric depression: a pilot study combining sleep deprivation and paroxetine. Depress Anxiety. 1997;6(3):113–8.
58. Caliyurt O, Guducu F. Partial sleep deprivation therapy combined with sertraline induces more rapid improvements in quality of life items in major depressive disorder. J Affect Disord. 2005;88(1):75–8.
59. Wu JC, Gillin JC, Buchsbaum MS, Schachat C, Darnall LA, Keator DB, et al. Sleep deprivation pet correlations of Hamilton symptom improvement ratings with changes in relative glucose metabolism in patients with depression. J Affect Disord. 2008;107(1–3):181–6.
60. Kuhs H, Farber D, Borgstadt S, Mrosek S, Tolle R. Amitriptyline in combination with repeated late sleep deprivation versus amitriptyline alone in major depression. A randomised study. J Affect Disord. 1996;37(1):31–41.
61. Elsenga S, van den Hoofdakker RH. Clinical effects of sleep deprivation and clomipramine in endogenous depression. J Psychiatr Res. 1982;17(4):361–74.
62. Shelton RC, Loosen PT. Sleep deprivation accelerates the response to nortriptyline. Prog Neuropsychopharmacol Biol Psychiatry. 1993;17(1):113–23.
63. Benedetti F, Barbini B, Bernasconi A, Fulgosi MC, Campori E, Colombo C, et al. Lithium overcomes the influence of 5-httlpr gene polymorphism on antidepressant response to sleep deprivation. J Clin Psychopharmacol. 2008;28(2):249–51.
64. Szuba MP, Baxter Jr LR, Altshuler LL, Allen EM, Guze BH, Schwartz JM, et al. Lithium sustains the acute antidepressant effects of sleep deprivation: preliminary findings from a controlled study. Psychiatry Res. 1994;51(3):283–95.
65. Altshuler L, Kiriakos L, Calcagno J, Goodman R, Gitlin M, Frye M, et al. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry. 2001;62(8):612–6.
66. Benedetti F, Riccaboni R, Locatelli C, Poletti S, Dallaspezia S, Colombo C. Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression. J Clin Psychiatry. 2014;75(2):133–40.
67. Millan MJ. Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther. 2006;110(2):135–370.
68. Ebert D, Berger M. Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation. Psychopharmacol (Berl). 1998;140(1):1–10.
69. Benedetti F, Bernasconi A, Blasi V, Cadioli M, Colombo C, Falini A, et al. Neural and genetic correlates of antidepressant response to sleep deprivation: a fMRI study of moral valence decision in bipolar depression. Arch Gen Psychiatry. 2007;64(2):179–87.
70. Benedetti F, Serretti A, Colombo C, Campori E, Barbini B, Di Bella D, et al. Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am J Psychiatry. 1999;156:1450–2.
71. Benedetti F, Barbini B, Bernasconi A, Fulgosi MC, Colombo C, Dallaspezia S, et al. Serotonin 5-HT2A receptor gene variants influence antidepressant response to repeated total sleep deprivation in bipolar depression. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(8):1863–6.
72. Gerner RH, Post RM, Gillin JC, Bunney Jr WE. Biological and behavioral effects of one night's sleep deprivation in depressed patients and normals. J Psychiatr Res. 1979;15(1):21–40.
73. Ebert D, Feistel H, Kaschka W, Barocka A, Pirner A. Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation—preliminary results. Biol Psychiatry. 1994;35(11):880–5.
74. Benedetti F, Calabrese G, Bernasconi A, Cadioli M, Colombo C, Dallaspezia S, et al. Spectroscopic correlates of antidepressant response to sleep deprivation and light therapy: a 3.0 Tesla study of bipolar depression. Psychiatry Res. 2009;173(3):238–42.
75. Elliott R, Rubinsztein JS, Sahakian BJ, Dolan RJ. The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry. 2002;59(7):597–604.
76. Benedetti F, Bernasconi A, Blasi V, Cadioli M, Colombo C, Falini A, et al. Neural and genetic correlates of antidepressant response to sleep deprivation: a functional magnetic resonance imaging study of moral valence decision in bipolar depression. Arch Gen Psychiatry. 2007;64(2):179–87.
77. Gillin JC, Buchsbaum M, Wu J, Clark C, Bunney Jr W. Sleep deprivation as a model experimental antidepressant treatment: findings from functional brain imaging. Depress Anxiety. 2001;14(1):37–49.
78. Wirz-Justice A, Van den Hoofdakker RH. Sleep deprivation in depression: what do we know, where do we go? Biol Psychiatry. 1999;46(4):445–53.
79. Mongrain V, La Spada F, Curie T, Franken P. Sleep loss reduces the DNA-binding of BMAL1, CLOCK, and NPAS2 to specific clock genes in the mouse cerebral cortex. PLoS ONE. 2011;6(10), e26622.
80. Harvey AG. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry. 2008;165(7):820–9.
81. Canali P, Sferrazza Papa G, Casali AG, Schiena G, Fecchio M, Pigorini A, et al. Changes of cortical excitability as markers of antidepressant response in bipolar depression: preliminary data obtained by combining transcranial magnetic stimulation (TMS) and electroencephalography (EEG). Bipolar Disord. 2014;16(8):809–19. This is the first clinical trial investigating synaptic building and down scaling during TSD cycles in Bipolar Disorder by means of combined TMS/EEG.
82. Benedetti F, Dallaspezia S, Fulgosi MC, Barbini B, Colombo C, Smeraldi E. Phase advance is an actimetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depression. Chronobiol Int. 2007;24(5):921–37.
83. Tononi G, Cirelli C. Sleep function and synaptic homeostasis. Sleep Med Rev. 2006;10(1):49–62.
84. Bushey D, Tononi G, Cirelli C. Sleep and synaptic homeostasis: structural evidence in drosophila. Science. 2011;332(6037):1576–81.
85. Bunney BG, Bunney WE: Mechanisms of rapid antidepressant effects of sleep deprivation therapy: clock genes and circadian rhythms. Biol Psychiatry. 2012.
86. Wehr TA, Wirz-Justice A, Goodwin FK, Duncan W, Gillin JC. Phase advance of the circadian sleep-wake cycle as an antidepressant. Science. 1979;206(4419):710–3.
87. Surridge-David M, MacLean A, Coulter ME, Knowles JB. Mood change following an acute delay of sleep. Psychiatry Res. 1987;22(2):149–58.
88. David MM, MacLean AW, Knowles JB, Coulter ME. Rapid eye movement latency and mood following a delay of bedtime in healthy subjects: do the effects mimic changes in depressive illness? Acta Psychiatr Scand. 1991;84(1):33–9.
89. Jauhar P, Weller MP. Psychiatric morbidity and time zone changes: a study of patients from Heathrow airport. Br J Psychiatry. 1982;140:231–5.
90. Sack DA, Nurnberger J, Rosenthal NE, Ashburn E, Wehr TA. Potentiation of antidepressant medications by phase advance of the sleep-wake cycle. Am J Psychiatry. 1985;142(5):606–8.
91. Wu JC, Kelsoe JR, Schachat C, Bunney BG, DeModena A, Golshan S, et al. Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry. 2009;66(3):298–301.
92. Echizenya M, Suda H, Takeshima M, Inomata Y, Shimizu T. Total sleep deprivation followed by sleep phase advance and bright light therapy in drug-resistant mood disorders. J Affect Disord. 2013;144(1–2):28–33. This paper shows effectiveness of antidepressant chronotherapeutics even in drug resistant patients.
93. Wehr TA, Wirz-Justice A: Internal coincidence model for sleep deprivation and depression. In: Sleep Koella WP (Ed) Karger, Basel. 1981;26–33.
94. Lewy AJ, Lefler BJ, Emens JS, Bauer VK. The circadian basis of winter depression. Proc Natl Acad Sci U S A. 2006;103(19):7414–9.
95. Bhattacharjee Y. Psychiatric research. Is internal timing key to mental health? Science. 2007;317(5844):1488–90.
96. Robillard R, Naismith SL, Rogers NL, Ip TK, Hermens DF, Scott EM, et al. Delayed sleep phase in young people with unipolar or bipolar affective disorders. J Affect Disord. 2013;145(2):260–3.
97. Robillard R, Naismith SL, Rogers NL, Scott EM, Ip TK, Hermens DF, et al. Sleep-wake cycle and melatonin rhythms in adolescents and young adults with mood disorders: comparison of unipolar and bipolar phenotypes. Eur Psychiatry. 2013;28(7):412–6.
98. Gangwisch JE, Babiss LA, Malaspina D, Turner JB, Zammit GK, Posner K. Earlier parental set bedtimes as a protective factor against depression and suicidal ideation. Sleep. 2010;33(1):97–106.
99. Kripke D. Photoperiodic mechanisms for depression and its treatment. In: Perris C, Struwe G, Jansson B, editors. Biological psychiatry. Amsterdam: Elsevier; 1981. p. 1249–52.
100. Kripke DF, Risch SC, Janowsky D. Bright white light alleviates depression. Psychiatry Res. 1983;10(2):105–12.
101. Lewy AJ, Kern HA, Rosenthal NE, Wehr TA. Bright artificial light treatment of a manic-depressive patient with a seasonal mood cycle. Am J Psychiatry. 1982;139(11):1496–8.
102. Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr. 2005;10(8):647–63. quiz 672.
103. Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005;162(4):656–62.
104. Terman M. Evolving applications of light therapy. Sleep Med Rev. 2007;11(6):497–507.
105. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, et al. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41(1):72–80.
106. Winkler D, Pjrek E, Iwaki R, Kasper S. Treatment of seasonal affective disorder. Expert Rev Neurother. 2006;6(7):1039–48.
107. Terman M, Terman JS. Bright light therapy: side effects and benefits across the symptom spectrum. J Clin Psychiatry. 1999;60(11):799–808. quiz 809.
108. Terman JS, Terman M, Lo ES, Cooper TB. Circadian time of morning light administration and therapeutic response in winter depression. Arch Gen Psychiatry. 2001;58(1):69–75.
109. Terman M, Terman JS, Ross DC. A controlled trial of timed bright light and negative air ionization for treatment of winter depression. Arch Gen Psychiatry. 1998;55(10):875–82.
110. Terman M, Terman JS, Quitkin FM, McGrath PJ, Stewart JW, Rafferty B. Light therapy for seasonal affective disorder. A review of efficacy. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol. 1989;2(1):1–22.
111. Terman JS, Terman M, Schlager D, Rafferty B, Rosofsky M, Link MJ, et al. Efficacy of brief, intense light exposure for treatment of winter depression. Psychopharmacol Bull. 1990;26(1):3–11.
112. Eastman CI, Young MA, Fogg LF, Liu L, Meaden PM. Bright light treatment of winter depression: a placebo-controlled trial. Arch Gen Psychiatry. 1998;55(10):883–9.
113. Lewy AJ, Bauer VK, Cutler NL, Sack RL, Ahmed S, Thomas KH, et al. Morning vs evening light treatment of patients with winter depression. Arch Gen Psychiatry. 1998;55(10):890–6.
114. Labbate LA, Lafer B, Thibault A, Sachs GS. Side effects induced by bright light treatment for seasonal affective disorder. J Clin Psychiatry. 1994;55(5):189–91.
115. Benedetti F, Colombo C, Pontiggia A, Bernasconi A, Florita M, Smeraldi E. Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial. J Clin Psychiatry. 2003;64(6):648–53.
116. Martiny K, Lunde M, Unden M, Dam H, Bech P. Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales. Acta Psychiatr Scand. 2005;112(2):117–25.
117. Kripke DF. Light treatment for nonseasonal depression: speed, efficacy, and combined treatment. J Affect Disord. 1998;49(2):109–17.
118. Lam RW, Carter D, Misri S, Kuan AJ, Yatham LN, Zis AP. A controlled study of light therapy in women with late luteal phase dysphoric disorder. Psychiatry Res. 1999;86(3):185–92.
119. Lam RW, Goldner EM, Solyom L, Remick RA. A controlled study of light therapy for bulimia nervosa. Am J Psychiatry. 1994;151(5):744–50.
120. Braun DL, Sunday SR, Fornari VM, Halmi KA. Bright light therapy decreases winter binge frequency in women with bulimia nervosa: a double-blind, placebo-controlled study. Compr Psychiatry. 1999;40(6):442–8.
121. Oren DA, Wisner KL, Spinelli M, Epperson CN, Peindl KS, Terman JS, et al. An open trial of morning light therapy for treatment of antepartum depression. Am J Psychiatry. 2002;159(4):666–9.
122. Wirz-Justice A, Bader A, Frisch U, Stieglitz RD, Alder J, Bitzer J, et al. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression. J Clin Psychiatry. 2011;72(7):986–93.
123. Rybak YE, McNeely HE, Mackenzie BE, Jain UR, Levitan RD. An open trial of light therapy in adult attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2006;67(10):1527–35.
124. Skjerve A, Bjorvatn B, Holsten F. Light therapy for behavioural and psychological symptoms of dementia. Int J Geriatr Psychiatry. 2004;19(6):516–22.
125. Lieverse R, Van Someren EJ, Nielen MM, Uitdehaag BM, Smit JH, Hoogendijk WJ. Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial. Arch Gen Psychiatry. 2011;68(1):61–70.
126. Prasko J, Brunovsky M, Latalova K, Grambal A, Raszka M, Vyskocilova J, et al. Augmentation of antidepressants with bright light therapy in patients with comorbid depression and borderline personality disorder. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010;154(4):355–61.
127. Papatheodorou G, Kutcher S. The effect of adjunctive light therapy on ameliorating breakthrough depressive symptoms in adolescent-onset bipolar disorder. J Psychiatry Neurosci. 1995;20(3):226–32.
128. Leibenluft E, Turner EH, Feldman-Naim S, Schwartz PJ, Wehr TA, Rosenthal NE. Light therapy in patients with rapid cycling bipolar disorder: preliminary results. Psychopharmacol Bull. 1995;31(4):705–10.
129. Goel N, Terman M, Terman JS, Macchi MM, Stewart JW. Controlled trial of bright light and negative air ions for chronic depression. Psychol Med. 2005;35(7):945–55.
130. Sit D, Wisner KL, Hanusa BH, Stull S, Terman M. Light therapy for bipolar disorder: a case series in women. Bipolar Disord. 2007;9(8):918–27.
131. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, et al. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41(1):72–80.
132. Dauphinais DR, Rosenthal JZ, Terman M, DiFebo HM, Tuggle C, Rosenthal NE. Controlled trial of safety and efficacy of bright light therapy vs. negative air ions in patients with bipolar depression. Psychiatry Res. 2012;196(1):57–61.
133. Goel N, Terman M, Terman JS. Dimensions of temperament and bright light response in seasonal affective disorder. Psychiatry Res. 2003;119(1–2):89–97.
134. Heim M. Effectiveness of bright light therapy in cyclothymic axis syndromes—a cross-over study in comparison with partial sleep deprivation. Psychiatry Neurol Med Psychol (Leipz). 1988;40(5):269–77.
135. Benedetti F, Barbini B, Fulgosi MC, Colombo C, Dallaspezia S, Pontiggia A, et al. Combined total sleep deprivation and light therapy in the treatment of drug-resistant bipolar depression: acute response and long-term remission rates. J Clin Psychiatry. 2005;66(12):1535–40.
136. Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4(2):97–110.
137. Avery DH, Dahl K, Savage MV, Brengelmann GL, Larsen LH, Kenny MA, et al. Circadian temperature and cortisol rhythms during a constant routine are phase-delayed in hypersomnic winter depression. Biol Psychiatry. 1997;41(11):1109–23.
138. Dahl K, Avery DH, Lewy AJ, Savage MV, Brengelmann GL, Larsen LH, et al. Dim light melatonin onset and circadian temperature during a constant routine in hypersomnic winter depression. Acta Psychiatr Scand. 1993;88(1):60–6.
139. Lewy AJ, Lefler BJ, Emens JS, Bauer VK. The circadian basis of winter depression. Proc Natl Acad Sci U S A. 2006;103(19):7414–9.
140. Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295(5557):1070–3.
141. Hannibal J, Hindersson P, Knudsen SM, Georg B, Fahrenkrug J. The photopigment melanopsin is exclusively present in pituitary adenylate cyclase-activating polypeptide-containing retinal ganglion cells of the retinohypothalamic tract. J Neurosci: Off J Soc Neurosci. 2002;22(1):RC191.
142. Dacey DM, Liao HW, Peterson BB, Robinson FR, Smith VC, Pokorny J, et al. Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature. 2005;433(7027):749–54.
143. Lockley SW, Brainard GC, Czeisler CA. High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab. 2003;88(9):4502–5.
144. Strong RE, Marchant BK, Reimherr FW, Williams E, Soni P, Mestas R. Narrow-band blue-light treatment of seasonal affective disorder in adults and the influence of additional nonseasonal symptoms. Depress Anxiety. 2009;26(3):273–8.
145. Meesters Y, Dekker V, Schlangen LJ, Bos EH, Ruiter MJ: Low-intensity blue-enriched white light (750 lux) and standard bright light (10,000 lux) are equally effective in treating sad. A randomized controlled study. BMC Psychiatry. 2011; 11(17).
146. Terman M, Schlager D, Fairhurst S, Perlman B. Dawn and dusk simulation as a therapeutic intervention. Biol Psychiatry. 1989;25(7):966–70.
147. Avery DH, Kouri ME, Monaghan K, Bolte MA, Hellekson C, Eder D. Is dawn simulation effective in ameliorating the difficulty awakening in seasonal affective disorder associated with hypersomnia? J Affect Disord. 2002;69(1–3):231–6.
148. Lingjaerde O, Foreland AR, Dankertsen J. Dawn simulation vs. lightbox treatment in winter depression: a comparative study. Acta Psychiatr Scand. 1998;98(1):73–80.
149. Avery DH, Eder DN, Bolte MA, Hellekson CJ, Dunner DL, Vitiello MV, et al. Dawn simulation and bright light in the treatment of sad: a controlled study. Biol Psychiatry. 2001;50(3):205–16.
150. Terman M, Terman JS. Controlled trial of naturalistic dawn simulation and negative air ionization for seasonal affective disorder. Am J Psychiatry. 2006;163(12):2126–33.
151. Danilenko KV, Ivanova IA. Dawn simulation vs. bright light in seasonal affective disorder: treatment effects and subjective preference. J Affect Disord. 2015;180:7–89.
152. Lewy AJ, Emens JS, Songer JB, Sims N, Laurie AL, Fiala SC, et al. Winter depression: integrating mood, circadian rhythms, and the sleep/wake and light/dark cycles into a bio-psycho-social-environmental model. Sleep Med Clin. 2009;4(2):285–99.
153. Lam RW, Zis AP, Grewal A, Delgado PL, Charney DS, Krystal JH. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch Gen Psychiatry. 1996;53(1):41–4.
154. Neumeister A, Praschak-Rieder N, Besselmann B, Rao ML, Gluck J, Kasper S. Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy. Arch Gen Psychiatry. 1997;54(2):133–8.
155. Neumeister A, Turner EH, Matthews JR, Postolache TT, Barnett RL, Rauh M, et al. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry. 1998;55(6):524–30.
156. Harrison SJ, Tyrer AE, Levitan RD, Xu X, Houle S, Wilson AA, Nobrega JN, Rusjan PM, Meyer JH: Light therapy and serotonin transporter binding in the anterior cingulate and prefrontal cortex. Acta Psychiatr Scand. 2015.
157. Barbini B, Benedetti F, Colombo C, Dotoli D, Bernasconi A, Cigala-Fulgosi M, et al. Dark therapy for mania: a pilot study. Bipolar Disord. 2005;7(1):98–101.
158. Barbini B, Bertelli S, Colombo C, Smeraldi E. Sleep loss, a possible factor in augmenting manic episode. Psychiatry Res. 1996;65(2):121–5.
159. Wehr TA, Sack DA, Norman E. Treatment of rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biol Psychiatry. 1998;43(11):822–8.
160. Wirz-Justice A, Quinto C, Cajochen C, Werth E, Hock C. A rapid-cycling bipolar patient treated with long nights, bedrest, and light. Biol Psychiatry. 1999;45(8):1075–7.
161. Burkhart K, Phelps JR. Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiol Int. 2009;26(8):1602–12.
162. Lewy AJ, Nurnberger Jr JI, Wehr TA, Pack D, Becker LE, Powell RL, et al. Supersensitivity to light: possible trait marker for manic-depressive illness. Am J Psychiatry. 1985;142(6):725–7.
163. Wehr TA, Sack DA, Norman E. Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry. 1987;144:201–4.
164. Wood B, Rea MS, Plitnick B, Figueiro MG. Light level and duration of exposure determine the impact of self-luminous tablets on melatonin suppression. Appl Ergon. 2013;44(2):237–40.
165. Terman M, Schlager D, Fairhurst S, Perlman B. Dawn and dusk simulation as a therapeutic intervention. Biol Psychiatry. 1989;25(7):966–70.
166. Fontana Gasio P, Krauchi K, Cajochen C, Someren E, Amrhein I, Pache M, et al. Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly. Exp Gerontol. 2003;38(1–2):207–16.
167. Boyce P, Hopwood M. Manipulating melatonin in managing mood. Acta Psychiatr Scand Suppl. 2013;444:16–23.
168. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(9):655–79.
169. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYS) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2197–223.
170. Crown WH, Finkelstein S, Berndt ER, Ling D, Poret AW, Rush AJ, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry. 2002;63(11):963–71.